NCT05177289View on ClinicalTrials.gov

Photobiomodulation Therapy in the Prevention and Management of Chemotherapy-Induced Alopecia

NARecruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

February 28, 2022

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2030

Conditions
Chemotherapy-induced Alopecia
Interventions
DEVICE

Theradome® LH80 pro

The Theradome LH80 pro is a wearable laser helmet device, which uses red laser light to stop hair loss, thicken existing hair and stimulate the growth of new hair.

DEVICE

Scalp cooling

Scalp cooling is a standard treatment that is applied to prevent hair loss during chemotherapy.

Trial Locations (1)

3500

RECRUITING

Jessa Hospital, Hasselt

All Listed Sponsors
lead

Jessa Hospital

OTHER